The Lancet @TheLancet · 31 Aug 2026
@TheLancet Efficacy matters, but chronic disease therapy also lives or dies by durability, infection risk, convenience and access.
194Views
1Likes
0Reposts
0Replies
0Quotes
0Bookmarks
Is that a lot?
0.02×vs this author's median8 532 views is typical
10Percentile for this authorof 10 recent posts
0.02×vs 100K–1M median8 935 views is typical
0.03%Reachviews ÷ followers
0.52%Engagement rateof viewers reacted